首页 | 本学科首页   官方微博 | 高级检索  
     

硼替佐米为主方案治疗难治/复发轻链型多发性骨髓瘤
引用本文:吴亚妹,王志红,马健,曹永彬,徐丽昕,刘蓓,闫蓓,刘周阳,吴晓雄,高春记,达万明.硼替佐米为主方案治疗难治/复发轻链型多发性骨髓瘤[J].压电与声光,2010(1):19-21.
作者姓名:吴亚妹  王志红  马健  曹永彬  徐丽昕  刘蓓  闫蓓  刘周阳  吴晓雄  高春记  达万明
作者单位:[1]解放军总医院304临床部血液科,北京100048 [2]解放军总医院血液科,北京100853
摘    要:目的了解硼替佐米对难治/复发性轻链型多发性骨髓瘤的疗效。方法采用BD/BP、BAD/BAP、BAEP及BVAD方案治疗14例轻链型MM患者。结果14例患者中,CR1例,nCR2例,PR5例,ORR8例。6例合并肾功能不全患者与8例肾功能正常患者的疗效相近。不良反应主要有乏力、胃肠道反应、末梢神经炎、血小板减少等,均可耐受。结论硼替佐米对部分已对化疗耐药的难治/复发性轻链型MM仍然有效,且效果显著。

关 键 词:多发性骨髓瘤  硼替佐米  治疗结果

Effects of bortezomib on refractory or relapsed light-chain multiple myeloma
WU Ya-mei,WANG Zhi-hong,MA Jian,CAO Yong-bin,XU Li-xin,LIU Pei,YAN Pei,LIU Zhou-yang,WU Xiao-xiong,GAO Chun-ji,DA Wan-ming.Effects of bortezomib on refractory or relapsed light-chain multiple myeloma[J].Piezoelectrics & Acoustooptics,2010(1):19-21.
Authors:WU Ya-mei  WANG Zhi-hong  MA Jian  CAO Yong-bin  XU Li-xin  LIU Pei  YAN Pei  LIU Zhou-yang  WU Xiao-xiong  GAO Chun-ji  DA Wan-ming
Affiliation:WU Ya-mei1,WANG Zhi-hong1,MA Jian1,CAO Yong-bin1,XU Li-xin1,LIU Pei1,YAN Pei1,LIU Zhou-yang1,WU Xiao-xiong1,GAO Chun-ji2,DA Wan-ming21Department of Hematology,304 Clinical Division,Chinese PLA General Hospital,Beijing 100048,China,2Department of Hematology,Beijing 100853
Abstract:Objective To elucidate the curative effects and toxicity of bortezomib on refractory or relapsed light-chain multiple myeloma (MM). Methods Fourteen patients with refractory or relapsed light-chain MM were treated with BD/BP, BAD/BAP, and BAEP or BVAD. Results The complete, near complete, and partial remission rate was 7.1%(1/14), 14.2%(2/14), and 35.7%(5/11), respectively, with an overall response rate of 57.1%. The response rate of patients with and without renal impairment was similar. The main toxicitie...
Keywords:Multiple Myeloma  Bortezomib  Treatment Outcome  
点击此处可从《压电与声光》浏览原始摘要信息
点击此处可从《压电与声光》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号